Lazzaro Medical, founded with a mission to revolutionize patient care, focuses on providing innovative robotic procedures and diagnostics for tracheobronchomalacia (TBM), a degenerative disease causing airway collapse. Their core vision is to assist millions of patients suffering from TBM by offering advanced medical solutions that improve breathing and overall quality of life. Lazzaro Medical's primary product offerings include cutting-edge robotic technologies designed to diagnose and treat TBM more effectively than traditional methods.

Notable figures affiliated with Lazzaro Medical include leading experts in the fields of robotics and pulmonology, though specific names are not provided. The company has garnered attention from prominent investors in the healthcare technology sector, reflecting confidence in their innovative approach. Key achievements include the development of transformative robotic procedures that have significantly improved patient outcomes. Overall, Lazzaro Medical has made a substantial impact by addressing a critical need in respiratory healthcare, enhancing the lives of those affected by TBM.